These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 28762087)
1. Non-Small-Cell Lung Cancer (NSCLC) Harboring ALK Translocations: Clinical Characteristics and Management in a Real-Life Setting: a French Retrospective Analysis (GFPC 02-14 Study). Auliac JB; Monnet I; Dubos-Arvis C; Chiappa AM; Baize N; Bota S; Vergnenegre A; Doubre H; Locher C; Bizieux A; Robinet G; Chouaid C Target Oncol; 2017 Dec; 12(6):833-838. PubMed ID: 28762087 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of programmed cell-death-protein-1 and its ligand inhibitors in pretreated patients with epidermal growth-factor receptor-mutated or anaplastic lymphoma kinase-translocated lung adenocarcinoma. Bylicki O; Guisier F; Monnet I; Doubre H; Gervais R; Janicot H; Perol M; Fournel P; Lamy R; Auliac JB; Chouaid C Medicine (Baltimore); 2020 Jan; 99(3):e18726. PubMed ID: 32011450 [TBL] [Abstract][Full Text] [Related]
3. Anaplastic lymphoma kinase gene rearrangement predicts better prognosis in NSCLC patients: A meta-analysis. Wang Z; Yang H; Luo S; Liu B; Zhang N; Li L; Zhou S; Shen R; Xie X Lung Cancer; 2017 Oct; 112():1-9. PubMed ID: 29191580 [TBL] [Abstract][Full Text] [Related]
4. Clinical Outcome of ALK-Positive Non-Small Cell Lung Cancer (NSCLC) Patients with De Novo EGFR or KRAS Co-Mutations Receiving Tyrosine Kinase Inhibitors (TKIs). Schmid S; Gautschi O; Rothschild S; Mark M; Froesch P; Klingbiel D; Reichegger H; Jochum W; Diebold J; Früh M J Thorac Oncol; 2017 Apr; 12(4):681-688. PubMed ID: 28007627 [TBL] [Abstract][Full Text] [Related]
5. Non-Small Cell Lung Cancer Patients Harboring HER2 Mutations: Clinical Characteristics and Management in a Real-Life Setting. Cohort HER2 EXPLORE GFPC 02-14. Auliac JB; Dô P; Bayle S; Doubre H; Vinas F; Letreut J; Falchero L; Hauss PA; Thomas P; Chouaid C Adv Ther; 2019 Aug; 36(8):2161-2166. PubMed ID: 31154630 [TBL] [Abstract][Full Text] [Related]
6. Characteristics and outcomes of ALK+ non-small cell lung cancer patients in Korea. Lim SH; Yoh KA; Lee JS; Ahn MJ; Kim YJ; Kim SH; Zhang J; Patel D; Swallow E; Kageleiry A; Galebach P; Lee D; Stein K; Degun R; Park K Asia Pac J Clin Oncol; 2017 Oct; 13(5):e239-e245. PubMed ID: 28419723 [TBL] [Abstract][Full Text] [Related]
7. Progression-Free and Overall Survival of Patients With ALK Rearrangement-Positive Non-Small Cell Lung Cancer Treated Sequentially With Crizotinib and Alectinib. Watanabe S; Hayashi H; Okamoto K; Fujiwara K; Hasegawa Y; Kaneda H; Tanaka K; Takeda M; Nakagawa K Clin Lung Cancer; 2016 Nov; 17(6):528-534. PubMed ID: 27318655 [TBL] [Abstract][Full Text] [Related]
8. Patients with non-small-cell lung cancer harbouring a Auliac JB; Bayle S; Vergnenegre A; Le Caer H; Falchero L; Gervais R; Doubre H; Vinas F; Marin B; Chouaid C Curr Oncol; 2018 Oct; 25(5):e398-e402. PubMed ID: 30464690 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of Pemetrexed-based Chemotherapy in Comparison to Non-Pemetrexed-based Chemotherapy in Advanced, ALK+ Non-Small Cell Lung Cancer. Jo J; Kim SH; Kim YJ; Lee J; Kim M; Keam B; Kim TM; Kim DW; Heo DS; Chung JH; Jeon YK; Lee JS Yonsei Med J; 2018 Mar; 59(2):202-210. PubMed ID: 29436187 [TBL] [Abstract][Full Text] [Related]
10. Characteristics and Outcomes of Patients with Lung Cancer Harboring Multiple Molecular Alterations: Results from the IFCT Study Biomarkers France. Guibert N; Barlesi F; Descourt R; Léna H; Besse B; Beau-Faller M; Mosser J; Pichon E; Merlio JP; Ouafik L; Guichard F; Mastroianni B; Moreau L; Wdowik A; Sabourin JC; Lemoine A; Missy P; Langlais A; Moro-Sibilot D; Mazières J J Thorac Oncol; 2017 Jun; 12(6):963-973. PubMed ID: 28189832 [TBL] [Abstract][Full Text] [Related]
11. ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations. Peretti U; Ferrara R; Pilotto S; Kinspergher S; Caccese M; Santo A; Brunelli M; Caliò A; Carbognin L; Sperduti I; Garassino M; Chilosi M; Scarpa A; Tortora G; Bria E Respir Res; 2016 Aug; 17(1):105. PubMed ID: 27561692 [TBL] [Abstract][Full Text] [Related]
13. Non-small cell lung cancer with EML4-ALK translocation in Chinese male never-smokers is characterized with early-onset. Guo Y; Ma J; Lyu X; Liu H; Wei B; Zhao J; Fu S; Ding L; Zhang J BMC Cancer; 2014 Nov; 14():834. PubMed ID: 25407901 [TBL] [Abstract][Full Text] [Related]
14. [Driven Gene in Patients with Lung Squamous Cell Carcinoma: Analysis of Clinicopathologic Characteristics and Prognosis]. Zhang T; Li J Zhongguo Fei Ai Za Zhi; 2016 Oct; 19(10):648-652. PubMed ID: 27760592 [TBL] [Abstract][Full Text] [Related]